Similar articles

Abstract: A high-performance liquid chromatography (HPLC) system was used in the reversed phase mode for the determination of benzalkonium chloride (BKC) in azithromycin viscous ophthalmic drops. A Venusil-XBP(L)-C₁₈ (150 mm×4.6 mm, 5 μm) column was used at 50 °C. The mobile phase consisted of a mixture of methanol-potassium phosphate (16:5, v/v). Two sample preparation methods were compared. The results suggested that, compared with an extraction procedure, a deproteinization procedure was much quicker and more convenient. Using the deproteinization procedure for sample preparation, calibration curves were linear in the range 5.0~50 μg/ml. The within-day and inter-day coefficients of variation were less than 10%. The average recoveries were determined as 96.70%, 98.52%, and 97.96% at concentrations of 10.0, 30.0, and 50.0 μg/ml, respectively. Variability in precision did not exceed 5%. In conclusion, this HPLC method using a simple sample treatment procedure appears suitable for monitoring BKC content in azithromycin viscous ophthalmic drops.

[1] Ali, Y., Lehmussaari, K., 2006. Industrial perspective in ocular drug delivery. Adv. Drug Deliv. Rev., 58(11):1258-1268.

[2] Anonymity, 2008. Ophthalmic azithromycin (AzaSite). Med. Lett. Drugs Ther., 50(1279):11-12.

[3] Aragona, P., Papa, V., Micali, A., Santocono, M., Milazzo, G., 2002. Long term treatment with sodium hyaluronate containing artificial tears reduces ocular surface damage in patients with dry eye. Br. J. Ophthalmol., 86(2):181-184.

[4] Bernal, J.L., Del-Nozal, M.J., Martín, M.T., Diez-Masa, J.C., Cifuentes, A., 1998. Quantitation of active ingredients and excipients in nasal sprays by high-performance liquid chromatography, capillary electrophoresis and UV spectroscopy. J. Chromatogr. A, 823(1-2):423-431.

[5] Bravo, R.H., 2009. USP NF (United States Pharmacopeia 32/National Formulary 27). United Book Press, Baltimore, Maryland, p.1173-1174.

[6] Chen, Q.F., Wang, X.L., 2005. Determination of benzalkonium chloride in ofloxacin eye drops by HPLC. Chin. J. Pharm., 36(9):564-566 (in Chinese).

[7] Choy, Y.B., Park, J.H., McCarey, B.E., Edelhauser, H.F., Prausnitz, M.R., 2008. Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time. Invest. Ophthalmol. Vis. Sci., 49(11):4808-4815.

[8] Deutschle, T., Porkert, U., Reiter, R., Keck, T., Riechelmann, H., 2006. In vitro genotoxicity and cytotoxicity of benzalkonium chloride. Toxicol. in Vitro, 20(8):1472-1477.

[9] Gomez-Gomar, A., Gonzalez-Aubert, M.M., Garces-Torrents, J., Costa-Segarra, J., 1990. Determination of benzalkonium chloride in aqueous ophthalmic preparations by high-performance liquid chromatography. J. Pharm. Biomed. Anal., 8(8-12):871-876.

[10] Hou, Y.H., Wu, C.Y., Ding, W.H., 2002. Development and validation of a capillary zone electrophoresis method for the determination of benzalkonium chlorides in ophthalmic solutions. J. Chromatogr. A, 976(1-2):207-213.

[11] Jiménez, M.M., Fresno, M.J., Ramírez, A., 2007. Rheological study of binary gels with Carbopol Ultrez 10 and hyaluronic acid. Chem. Pharm. Bull. (Tokyo), 55(8):1157-1163.

[12] Labranche, L.P., Dumont, S.N., Levesque, S., Carrier, A., 2007. Rapid determination of total benzalkonium chloride content in ophthalmic formulation. J. Pharm. Biomed. Anal., 43(3):989-993.

[13] Merianos, J.J., 1991. Quaternary Ammonium Antimicrobial Compounds. In: Block, S.S. (Ed.), Disinfection, Sterilization and Preservation, 4th Ed. Lea & Febiger, Malvern, PA, p.225-255.

[14] Prince, S.J., McLaury, H.J., Allen, L.V., McLaury, P., 1999. Analysis of benzalkonium chloride and its homologs: HPLC versus HPCE. J. Pharm. Biomed. Anal., 19(6): 877-882.

[15] Rojsitthisak, P., Wichitnithad, W., Pipitharome, O., Sanphanya, K., Thanawattanawanich, P., 2005. Simple HPLC determination of benzalkonium chloride in ophthalmic formulations containing antazoline and tetrahydrozoline. PDA J. Pharm. Sci. Technol., 59(5):332-337.

[16] Rozier, A., Mazuel, C., Grove, J., Plazonnet, B., 1997. Functionality testing of gellan gum, a polymeric excipient material for ophthalmic dosage forms. Int. J. Pharm., 153(2):191-198.

[17] Samalonis, L.B., 2006. Preservatives’ Role in Topical Ocular Drugs. Available from http://www.revophth.com/index.asp?page=1_1012.htm [Accessed on Oct. 12, 2009]

[18] Tatavarti, A.S., Hoag, S.W., 2006. Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices. J. Pharm. Sci., 95(7): 1459-1468.

[19] Winterton, L.C., Lally, J.M., Sentell, K.B., Chapoy, L.L., 2007. The elution of poly (vinyl alcohol) from a contact lens: the realization of a time release moisturizing agent/ artificial tear. J. Biomed. Mater. Res. B Appl. Biomater., 80(2):424-432.